Applications of carbonic anhydrase inhibitors and activators in therapy

Inhibitors and activators of the zinc enzyme carbonic anhydrase (CA, EC 4.2.1.1) have a large number of applications in therapy. Many types of such new derivatives have been reported recently, together with their potential applications as antiglaucoma, anticancer and anti-osteoporosis agents or for the management of a variety of neurological disorders, among others. Furthermore, some CA isozymes seem to be valuable markers of tumour progression in a variety of tissues and organs. The CA activators, although not clinically exploited up to now, seem to constitute a new revolutionary approach for the treatment of Alzheimer's disease and other neurodegenerative disorders in need of memory therapy. Recent progress in all these areas, as well as in the characterisation of new such enzymes/isozymes isolated in many organisms/tissues and their detailed catalytic/inhibition mechanisms are, reviewed in the present paper.

[1]  C. Supuran,et al.  Carbonic anhydrase inhibitors. Part 86. A QSAR study on some sulfonamide drugs which lower intra-ocular pressure, using the ACE non-linear statistical method. , 2000, European journal of medicinal chemistry.

[2]  D. Hewett‐Emmett,et al.  Mitochondrial carbonic anhydrase CA VB: differences in tissue distribution and pattern of evolution from those of CA VA suggest distinct physiological roles. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[3]  C. Supuran,et al.  Carbonic anhydrase inhibitors: 4-sulfamoyl-benzenecarboxamides and 4-chloro-3-sulfamoyl-benzenecarboxamides with strong topical antiglaucoma properties. , 2001, Bioorganic & medicinal chemistry letters.

[4]  C. Supuran,et al.  Carbonic anhydrase activators: design of high affinity isozymes I, II, and IV activators, incorporating tri-/tetrasubstituted-pyridinium-azole moieties. , 2002, Journal of medicinal chemistry.

[5]  C. Supuran,et al.  Carbonic Anhydrase Inhibitors: Synthesis and Inhibition Against Isozymes I, II and IV of Topically Acting Antiglaucoma Sulfonamides Incorporating cis-5-Norbornene-endo-3-Carboxy-2-Carboxamido Moieties , 2001, Journal of enzyme inhibition.

[6]  W. Sly,et al.  Expression of membrane-associated carbonic anhydrase XIV on neurons and axons in mouse and human brain. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[7]  M. Nicolela,et al.  Additive Effect of Latanoprost to the Combination of Timolol and Dorzolamide , 2000, Journal of glaucoma.

[8]  C. Supuran,et al.  Carbonic anhydrase activators: high affinity isozymes I, II, and IV activators, incorporating a beta-alanyl-histidine scaffold. , 2002, Journal of medicinal chemistry.

[9]  M Nakajima,et al.  [Matrix metalloproteinase inhibitors]. , 2000, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.

[10]  Orbital Symmetry in QSAR: Some Schiff's Base Inhibitors of Carbonic Anhydrase , 2001, SAR and QSAR in environmental research.

[11]  C. Supuran,et al.  Carbonic anhydrase inhibitors – part 70#. Synthesis and ocular pharmacology of a new class of water-soluble, topically effective intraocular pressure lowering agents derived from nicotinic acid and aromatic/heterocyclic sulfonamides , 1999 .

[12]  C. Supuran,et al.  Carbonic anhydrase inhibitors: synthesis of membrane-impermeant low molecular weight sulfonamides possessing in vivo selectivity for the membrane-bound versus cytosolic isozymes. , 2000, Journal of medicinal chemistry.

[13]  C. Supuran,et al.  Carbonic Anhydrase Inhibitors. Metal Complexes of 5-(2-Chlorophenyl)-1, 3, 4-Thiadiazole-2-Sulfonamide with Topical Intraocular Pressure Lowering Properties: The Influence of Metal Ions Upon the Pharmacological Activity , 2000, Journal of enzyme inhibition.

[14]  N. Suraveratum,et al.  Characterisation of carbonic anhydrase in Plasmodium falciparum. , 2001, International journal for parasitology.

[15]  A. Harris,et al.  Carbonic anhydrase IX, an endogenous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis, and microvessel density. , 2001, Cancer research.

[16]  Abdul Waheed,et al.  Nuclear NonO/p54nrb Protein Is a Nonclassical Carbonic Anhydrase* , 2000, The Journal of Biological Chemistry.

[17]  C. Supuran,et al.  Carbonic anhydrase inhibitors: sulfonamides as antitumor agents? , 2001, Bioorganic & medicinal chemistry.

[18]  J. Pullar,et al.  Glutathione Oxidation by Hypochlorous Acid in Endothelial Cells Produces Glutathione Sulfonamide as a Major Product but Not Glutathione Disulfide* , 2001, The Journal of Biological Chemistry.

[19]  Claudiu T. Supuran,et al.  Carbonic anhydrase inhibitors: water-soluble 4-sulfamoylphenylthioureas as topical intraocular pressure-lowering agents with long-lasting effects. , 2000, Journal of medicinal chemistry.

[20]  W. Sly,et al.  Purification and kinetic analysis of recombinant CA XII, a membrane carbonic anhydrase overexpressed in certain cancers. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[21]  D. Silverman,et al.  The catalytic properties of human carbonic anhydrase IX. , 2001, Biochemical and biophysical research communications.

[22]  W. Sly,et al.  Expression of the hypoxia-inducible and tumor-associated carbonic anhydrases in ductal carcinoma in situ of the breast. , 2001, The American journal of pathology.

[23]  THE ROLES OF CARBONIC ANHYDRASE ISOZYMES IN CANCER , 2001 .

[24]  Gerhard Klebe,et al.  Nonaromatic sulfonamide group as an ideal anchor for potent human carbonic anhydrase inhibitors: role of hydrogen-bonding networks in ligand binding and drug design. , 2002, Journal of medicinal chemistry.

[25]  Scozzafava,et al.  Carbonic Anhydrase Inhibitors. Synthesis of Topically Effective Intraocular Pressure Lowering Agents Derived from 5-(omega-Amino- alkylcarboxamido)-1,3,4-Thia- diazole-2-Sulfonamide. , 1999, Journal of enzyme inhibition.

[26]  G N Shah,et al.  Crystal structure of the dimeric extracellular domain of human carbonic anhydrase XII, a bitopic membrane protein overexpressed in certain cancer tumor cells , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[27]  F. Morel,et al.  A biological function for cadmium in marine diatoms. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[28]  C. Supuran,et al.  Carbonic anhydrase activators. Part 24. High affinity isozymes I, II and IV activators, derivatives of 4-(4-chlorophenylsulfonylureido-amino acyl)ethyl-1H-imidazole. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[29]  E. Pai,et al.  The active site architecture of Pisum sativum β‐carbonic anhydrase is a mirror image of that of α‐carbonic anhydrases , 2000 .

[30]  D. Rees,et al.  Crystal Structure of the “cab”-type β Class Carbonic Anhydrase from the Archaeon Methanobacterium thermoautotrophicum * , 2001, The Journal of Biological Chemistry.

[31]  S. Miyachi,et al.  X-ray Structure of β-Carbonic Anhydrase from the Red Alga,Porphyridium purpureum, Reveals a Novel Catalytic Site for CO2 Hydration* , 2000, The Journal of Biological Chemistry.

[32]  C. Supuran,et al.  Carbonic anhydrase inhibitors: perfluoroalkyl/aryl-substituted derivatives of aromatic/heterocyclic sulfonamides as topical intraocular pressure-lowering agents with prolonged duration of action. , 2000, Journal of medicinal chemistry.

[33]  D. Alkon,et al.  Pharmacological enhancement of synaptic efficacy, spatial learning, and memory through carbonic anhydrase activation in rats. , 2001, The Journal of pharmacology and experimental therapeutics.

[34]  G. Mclendon,et al.  The active site structure of Thalassiosira weissflogii carbonic anhydrase 1. , 2000, Biochemistry.

[35]  C. Supuran,et al.  Activation of carbonic anhydrase isozymes. , 2000, EXS.

[36]  Kam Y. J. Zhang,et al.  Crystal structure of E. coli β–carbonic anhydrase, an enzyme with an unusual pH–dependent activity , 2001, Protein science : a publication of the Protein Society.

[37]  C. Supuran,et al.  Carbonic Anhydrase Inhibitors: Synthesis of Schiff Bases of Hydroxybenzaldehydes with Aromatic Sulfonamides and Their Reactions with Arylsulfonyl Isocyanates , 2000, Journal of enzyme inhibition.

[38]  Abdul Waheed,et al.  Differential Expression of Cytoplasmic Carbonic Anhydrases, CA I and II, and Membrane-Associated Isozymes, CA IX and XII, in Normal Mucosa of Large Intestine and in Colorectal Tumors , 2001, Digestive Diseases and Sciences.

[39]  B. Friren,et al.  Comparison of topical brinzolamide 1% and dorzolamide 2% eye drops given twice daily in addition to timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension. , 2001, American journal of ophthalmology.

[40]  C. Supuran,et al.  Carbonic anhydrase activators: human isozyme II is strongly activated by oligopeptides incorporating the carboxyterminal sequence of the bicarbonate anion exchanger AE1. , 2002, Bioorganic & medicinal chemistry letters.

[41]  S. Lindskog,et al.  Cloning, expression and some properties of α-carbonic anhydrase from Helicobacter pylori , 2001 .

[42]  S Mangani,et al.  Carbonic anhydrase activators: X-ray crystallographic and spectroscopic investigations for the interaction of isozymes I and II with histamine. , 1997, Biochemistry.

[43]  C. Supuran,et al.  Carbonic Anhydrase Activators: Synthesis of High Affinity Isozymes I, II and IV Activators, Derivatives of 4-(Arylsulfonylureido-Amino Acyl)Ethyl-1H-Imidazole , 2000, Journal of enzyme inhibition.

[44]  C. Supuran,et al.  Carbonic Anhydrase Inhibitors, Interaction of Boron Derivatives with Isozymes I and II: A New Binding Site for Hydrophobic Inhibitors at the Entrance of the Active Site as shown by Docking Studies , 2001, Journal of enzyme inhibition.

[45]  A Casini,et al.  Carbonic anhydrase inhibitors: water-soluble 4-sulfamoylphenylthioureas as topical intraocular pressure-lowering agents with long-lasting effects. , 2000, Journal of medicinal chemistry.

[46]  R. Griggs,et al.  Randomized trials of dichlorphenamide in the periodic paralyses , 2000, Annals of neurology.

[47]  C. Supuran,et al.  Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes. , 2000, Journal of medicinal chemistry.

[48]  K. Taki,et al.  Preferential Acetazolamide-Induced Vasodilation Based on Vessel Size and Organ: Confirmation of Peripheral Vasodilation with Use of Colored Microspheres , 2001, Angiology.

[49]  W. Sly,et al.  Expression of the Membrane-associated Carbonic Anhydrase Isozyme XII in the Human Kidney and Renal Tumors , 2000, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[50]  A. Harris,et al.  Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix. , 2001, Cancer research.

[51]  C. Tu,et al.  Characterization of carbonic anhydrase from Neisseria gonorrhoeae. , 2001, European journal of biochemistry.

[52]  C. Supuran,et al.  Agents that target cysteine residues of biomolecules and their therapeutic potential , 2001 .

[53]  J. Pastorek,et al.  Transmembrane carbonic anhydrase, MN/CA IX, is a potential biomarker for biliary tumours. , 2001, Journal of hepatology.

[54]  D. Ormrod,et al.  Topical Dorzolamide 2%/Timolol 0.5% , 2000, Drugs & aging.

[55]  J. Selengut,et al.  Carbonic anhydrase III: the phosphatase activity is extrinsic. , 2000, Archives of biochemistry and biophysics.

[56]  S. Gross,et al.  2H-Thieno[3,2-e]- and [2,3-e]-1,2-thiazine-6-sulfonamide 1,1-dioxides as ocular hypotensive agents: synthesis, carbonic anhydrase inhibition and evaluation in the rabbit. , 2000, Bioorganic & medicinal chemistry.

[57]  C. Supuran,et al.  Carbonic anhydrase activators - part 21. Novel activators of isozymes I, II and IV incorporating carboxamido and ureido histamine moieties. , 2000, European journal of medicinal chemistry.

[58]  Claudiu T. Supuran,et al.  Carbonic anhydrase inhibitors - Part 94. 1,3,4-Thiadiazole-2-sulfonamide derivatives as antitumor agents? , 2000 .

[59]  R. Reithmeier,et al.  Identification of the carbonic anhydrase II binding site in the Cl(-)/HCO(3)(-) anion exchanger AE1. , 2000, Biochemistry.

[60]  C. Supuran,et al.  Antifungal Activity of Ag(I) and Zn(Ii) Complexes of Aminobenzolamide (5-Sulfanilylamido-1,3,4-Thiadiazole-2-Sulfonamide) Derivatives , 2000, Journal of enzyme inhibition.

[61]  M. Baican,et al.  Omeprazole has a dual mechanism of action: it inhibits both H(+)K(+)ATPase and gastric mucosa carbonic anhydrase enzyme in humans (in vitro and in vivo experiments). , 1999, The Journal of pharmacology and experimental therapeutics.

[62]  K. Gelatt,et al.  Changes in intraocular pressure associated with topical dorzolamide and oral methazolamide in glaucomatous dogs. , 2001, Veterinary ophthalmology.

[63]  D. Silverman,et al.  Structural and kinetic analysis of the chemical rescue of the proton transfer function of carbonic anhydrase II. , 2001, Biochemistry.

[64]  C. Supuran,et al.  Carbonic anhydrase inhibitors: synthesis of sulfonamides incorporating dtpa tails and of their zinc complexes with powerful topical antiglaucoma properties. , 2001, Bioorganic & medicinal chemistry letters.

[65]  G. Seong,et al.  Comparisons of Intraocular-Pressure- Lowering Efficacy and Side Effects of 2% Dorzolamide and 1% Brinzolamide , 2001, Ophthalmologica.

[66]  C. Supuran,et al.  Carbonic Anhydrase Inhibitors: Synthesis of Sulfonamides Incorporating 2, 4, 6–Trisubstituted-Pyridinium-Ethylcarboxamido Moieties Possessing Membrane-Impermeability and in Vivo Selectivity for the Membrane-Bound (CA IV) Versus the Cytosolic (CA I and CA II) Isozymes , 2000, Journal of enzyme inhibition.

[67]  P. Pandhi,et al.  Anticonvulsant activity of omeprazole in rats , 2001, Epilepsy Research.

[68]  Claudiu T. Supuran,et al.  Carbonic anhydrase inhibitors and their therapeutic potential , 2000 .

[69]  M. Komai,et al.  Zinc deficiency and taste dysfunction; contribution of carbonic anhydrase, a zinc-metalloenzyme, to normal taste sensation. , 2000, BioFactors.

[70]  A. Sevinç,et al.  THE EFFICACY OF ACETAZOLAMIDE ON VISUAL FUNCTIONS IN A PATIENT WITH CHOROID METASTASIS OF BREAST CARCINOMA , 2001, International journal of clinical practice.

[71]  M. Brin,et al.  Pharmacologic treatment of essential tremor. , 2000, Neurology.

[72]  C. Simons,et al.  PROTEINASE AND PEPTIDASE INHIBITION: recent potential targets for drug development , 2003 .

[73]  W. Sly,et al.  Carbonic anhydrase inhibitor suppresses invasion of renal cancer cells in vitro. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[74]  R. Tashian.  Keeping pace with a fast enzyme: steps and missteps. , 2000, EXS.

[75]  A. Harris,et al.  Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer. , 2001, Cancer research.

[76]  D. Christianson,et al.  Fluoroaromatic-fluoroaromatic interactions between inhibitors bound in the crystal lattice of human carbonic anhydrase II. , 2001, Journal of the American Chemical Society.

[77]  C. Supuran,et al.  A ternary complex of carbonic anhydrase: X-ray crystallographic structure of the adduct of human carbonic anhydrase II with the activator phenylalanine and the inhibitor azide , 1998 .

[78]  C. Supuran,et al.  Carbonic anhydrase inhibitors: synthesis of N-morpholylthiocarbonylsulfenylamino aromatic/heterocyclic sulfonamides and their interaction with isozymes I, II and IV. , 2000, Bioorganic & medicinal chemistry letters.

[79]  A. Harris,et al.  Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[80]  C. Supuran,et al.  Carbonic anhydrase inhibitors: sulfonamides incorporating furan-, thiophene- and pyrrole-carboxamido groups possess strong topical intraocular pressure lowering properties as aqueous suspensions. , 2000, Bioorganic & medicinal chemistry.

[81]  C. Supuran,et al.  Carbonic Anhydrase Activators: Synthesis of High Affinity Isozymes I, II and IV Activators, Derivatives of 4-(4-Tosylureido-Amino Acyl)Ethyl-1H-Imidazole (Histamine Derivatives) , 2000, Journal of enzyme inhibition.

[82]  T. Wolfensberger.  The role of carbonic anhydrase inhibitors in the management of macular edema , 2004, Documenta Ophthalmologica.

[83]  C. Supuran,et al.  Crystal analysis of aromatic sulfonamide binding to native and (Zn)2 adduct of human carbonic anhydrase I Michigan 1 , 2002 .

[84]  R. Fisher,et al.  Crystal structure of S‐glutathiolated carbonic anhydrase III , 2000, FEBS letters.

[85]  C. Supuran,et al.  Carbonic Anhydrase Inhibitors: Aromatic Sulfonamides and Disulfonamides Act as Efficient Tumor Growth Inhibitors , 2000, Journal of enzyme inhibition.

[86]  S. Parkkila,et al.  The identification of secreted carbonic anhydrase VI as a constitutive glycoprotein of human and rat milk , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[87]  L. Frulloni,et al.  Elevated Serum Levels of Antibodies to Carbonic Anhydrase I and II in Patients with Chronic Pancreatitis , 2000, Pancreas.

[88]  Andrea Scozzafava,et al.  Carbonic anhydrase inhibitors. , 2001, Medicinal research reviews.

[89]  C. Supuran,et al.  Carbonic Anhydrase Inhibitors: Inhibition of Isozymes I, II and IV by Sulfamide and Sulfamic Acid Derivatives , 2000, Journal of enzyme inhibition.